Neither state government nor former employees have a clue about how and when the plant will start
Shivani Chaturvedi | June 20, 2015 | Chennai
It has been more than three months the prime minister Narendra Modi indicated his government’s plan to restart Nokia plant at Sriperumbudur Tamil Nadu. However, there is no clarity among former employees of the company and the state government on how and when would it happen.
President of Centre of Indian Trade Unions (CITU), Tamil Nadu unit and CITU national vice president, A Sounderrajan told Governance Now that nothing has been done till date to restart the plant. The employees who were thrown out of their jobs are still jobless. "We have no clarity on what is going to happen," he added.
Joint commissioner of labour, Tamil Nadu, S Kalaivani said, "We are still in dark. No information has come to us till now. It is the centre that needs to take up the issue then only we could do anything on it."
Last month Nokia India had withdrawn its plea to sell Chennai plant. The company told the Delhi high court that it wants to withdraw its request to lift the freeze on its shuttered Chennai plant and sell it after a potential buyer had backed out.
Nokia had shut down its big mobile manufacturing facility at Sriperumbudur last year. The company had tax troubles and other legal issues. More than 30,000 people were affected by the shutdown of the Sriperumbudur facility, which has been one of the biggest in the world. With this, its dependent unit Foxconn announced the suspension of its operation in December last year, and then confirmed closure in February 10, affecting nearly 1700 employees.
In such unprecedented times, businesses are facing different kinds of risk, which has
The government’s recent notification to regulate digital media is an attempt to suppress all social media platforms including digital news platforms, Dr. Shama Mohamed, Congress Spokesperson, has said. Only digital news platforms are able to say what they want to say, so the government
India’s first indigenously produced Covid-19 vaccine, Covaxin, has shown an interim efficacy of 81% in Phase III trials for preventing the virus. Covaxin has been developed in India jointly by the Indian Council of Medical Research (ICMR) along with Bharat Biotech International Limited (BBIL). &
In order to expand the vaccination drive, the centre has allowed 29 private hospitals in Mumbai not empanelled in central and state health schemes to be designated as Covid Vaccination Centres (CVC). After a virtual meeting with the chief minister and the BMC commissioner Tuesday evening, th
India on Tuesday concluded the spectrum auction after a total of six rounds of bidding. The authorities described the response as better than expected, with total bids valued at Rs 77,814.80 crore. The quality of service and customer experience is expected to improve with deployment of additional spectrum
One of the most significant setbacks from the massive upheaval caused by the Covid-19 pandemic is its effect on food and nutrition security. The pandemic has compounded the already rampant social inequity by adversely affecting the socio-economic status of millions of families across the nation. In the giv